Hydroxyurea and its derivatives exhibit versatile biological activities. Hydroxyurea is currently used in the treatment of various neoplastic and non-neoplastic diseases such as cancer, sickle cell anemia and HIV (1). Derivatives of hydroxyurea were found to inhibit matrix zinc metaloproteinases (MMP), urease, carboanhydrase, carboxypeptidase, cyclooxygenase and 5-lipooxygenase. Early experiments on antibacterial properties and effects on tumor cell lines of hydroxyurea and low molecular mass derivatives were investigated in the 1960s (2-3). Recently, hydroxyurea was recognized as a leading compound in nitric oxide donor synthesis (4).
Bacterial cultures. -Escherichia coli DH5a, BL21(DE3) and the expression vector pET--25b(+) were obtained from Novagen (USA), pUC18 vector was from GE Healthcare Life Sciences (USA). E. coli DH5a (supE44 DlacU169(Q80lacZDM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1) -a strain with natural sensitivity to antibiotics, DH5a/pUC18-ermC' -a strain DH5a carrying a gene for methyltransferase ErmC', which renders E. coli resistant to erythromycin and other macrolide antibiotics (10) , and BL21(DE3)/pET25b(+)-sgm (FompT hsdS B (r B -m B -)gal dcm (DE3) -an expression strain of E. coli containing a gene for methyltransferase Sgm, which makes E. coli resistant to kanamycin and other 4,6-deoxystreptamine aminoglycosides were used (11) .
Measurement of bacterial growth in microtiter plates -microdilution assay. -Serial dilutions of test compounds were prepared by dilution of stock solutions, either with LB medium (for E. coli strain DH5a) or with LB medium supplemented with 100 mg L -1 of ampicillin (for E. coli strains DH5a/pUC18-ermC' and BL21(DE3)/pET25b(+)-sgm). The total volume in each well was 200 mL and final concentrations of test compounds in the wells, after the addition of all components, were 0.001, 0.01, 0.1 and 1 mol L -1 . The overnight bacterial culture was diluted in fresh LB medium (1:50) (E. coli DH5a) or in LB medium supplemented with 100 mg L -1 of ampicillin (E. coli DH5a/pUC18-ermC' and E. coli BL21(DE3)/pET25b(+)-sgm) and grown until OD 600 was 0.8-1. Cultures were diluted to approximately 5 × 10 5 cells mL -1 and an aliquot of 100 µL of the suspension was added to the wells containing serial dilutions of test compounds. Additional wells which contained only the corresponding dilutions of test compounds in growth medium, were used as controls for compounds that were either colored or showed some absorbance in the absence of bacteria. Each microtiter plate contained a control of sterility (200 µL of LB medium), bacterial growth control (100 µL of LB medium, for E. coli strain DH5a, or LB medium with ampicillin, for E. coli strains DH5a/pUC18-ermC' and BL21(DE3)/ pET25b(+)-sgm) and 100 µL of bacterial inoculum), and a control of compound sterility (150 µL of LB medium and 50 µL of highest concentration of test compound). Microtiter plates were incubated for 18 h at 37°C and bacterial growth was measured at 570 nm using a microplate reader Biohit BP 800 (Biohit, Finland).
Metabolic MTS assay. -Metabolic activity and the potential cytotoxic effect of test compounds were investigated using the CellTiter 96 ® AQ ueous One Solution Cell Proliferation Assay (Promega, USA). Fifty µL of the cell culture (2 × 10 5 cells mL -1 , i.e., 10 4 cells per well) or fifty µL of RPMI 1640 medium were transferred into the wells of a 96-microwell plate. Test compounds were initially dissolved in DMSO, serially diluted in culture medium and 50 mL of 2-fold dilution was added into each well to obtain the final concentration of 0.001, 0.01, 0.1 and 1 mmol L -1 . Controls contained the test model cells and culture medium (containing the same final concentration of DMSO, < 0.2 %), but no test compounds. A negative control (medium without cells but with test compounds) was used as a blank. Cells were incubated for 24, 48 and 72 hours before addition of 20 mL 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) and were additionally incubated in the dark at 37°C for the following 2 hours. The absorbance was measured at a wavelength of 490 nm using a microplate reader Victor 2 -1420 Multilabel Counter (PerkinElmer). Two series of experiments were performed in triplicates. Data were analyzed by the one-way analysis of variance (ANOVA). Because of accuracy of the method any difference was considered significant if larger than ± 20 % and at p < 0.05.
Manganese porphyrin test. -Spectrometric assay for nitric oxide was performed by modification of a previously published procedure (12) . A 1 mmol L -1 manganese(III)-5,10,15,20-tetrakis(N-ethylpyridinium-2-yl) porphyrin (MnTE-2-PyP 5+ ) with 1 mmol L -1 sodium L-ascorbate in PBS, pH 7.4 was prepared. Stock solutions of tested compounds were prepared by weighing an appropriate amount of compound and dissolving it in distilled water to a final concentration of 1 mmol L -1 . PBS solution (1 mL) was mixed with 1 mL of a freshly prepared solution of the tested compound. Spectra were measured in an airtight 1-cm quartz cuvette cell in a range of 350 to 600 nm. (13) , where a phosgene solution (20 % in toluene) was replaced with a solid triphosgene. Compound 1 was prepared by mixing 2.30 g (0.02 mol) of 1-H-benzotriazole with 1.19 g (0.004 mol) of triphosgene in dry tetrahydrofurane for 72 h. THF was evaporated and the solid product was suspended in water. The suspension was acidified with HCl (1:1) up to pH 3 and mixed for 3 hours. The solid product was filtered off and dried in vacuo over P 2 O 5 .
Benzotriazole N-carbamoyl derivatives (2, 3 and 4). -N-carbamoyl derivatives of benzotriazole were synthesized in the reaction of 1 with the corresponding hydroxylamine derivative in dioxane solution at room temperature (Scheme 1). Compound 1 (2.68 g, 0.01 mol), 0.01 mol of the corresponding hydroxylamine (1.60, 0.83 and 0.97 g of benzyloxyamine hydochloride, methoxyamine hydrochloride, and ethoxyamine hydoxychloride, respectively) and 1.1 g (0.01 mol) TEA were dissolved in 50 mL of dry dioxane. The solution was vigorously mixed for 48 h at room temperature. TEA´HCl was filtered off and washed with 10 mL of dioxane. The filtrate was evaporated to the consistency of oil and crystallized from water. The obtained product was filtered off, washed with HCl (pH 3), water and dried for 24 h in air and in vacuo over P 2 O 5 at room temperature.
N-benzyloxybiuret (6). -Compound 2 (2.68 g, 0.01 mol), 0.60 g (0.01 mol) of urea and 0.34 g (0.005 mol) of imidazole were heated at 130°C for 10 minutes. After cooling to room temeperature, the solid mixture was suspended in water and acidified with HCl to pH 3. The product was filtered off, washed with water and dried over P 2 O 5 .
4-(Benzyloxycabamoyl)aminobenzoic acid (7). -Compound 2 (2.68 g, 0.01 mol), 1.37 g (0.01 mol) of 4-aminobenzoic acid and 0.68 g (0.01 mol) of imidazole were mixed at 130°C for 15 minutes. The cooled mixture was suspended in water and acidified with HCl to pH 3. The white product was filtered off, washed with water, recrystallized from ethanol and dried in vacuo over P 2 O 5 .
N,N'-bisbenzyloxyurea (9). -Compound 2 (2.68 g, 0.01 mol), 1.60 g (0.01 mol) benzyloxyamine hydrochloride and 1.01 g (0.01 mol) TEA were suspended in 50 mL of dry dioxane. The reaction mixture was mixed for 48 hours at room temperature. TEA×HCl was filtered off and washed with 10 mL of dry dioxane. The solvent was removed and the obtained oil was crystallized with the addition of water. The white solid product was washed with HCl (pH 3) and water, recrystallized from ethyl acetate and hexane and dried over P 2 O 5 in vacuo. (5) , N-hydroxybiuret (12), 4-(hydroxyaminocarbonyl)aminobenzoic acid (13) , N-hydroxyurea (14) , N,N',N''-trihydroxyisocyanuric acid (16) and N,N',N''-trihydroxibiuret (15) A mixture of 1-(N-benzyloxycarbamoyl)benzotriazole (2) , N-benzyloxybiuret (6), 4-(benzyloxycabamoyl)aminobenzoic acid (7) , N-benzyloxyurea (8) , N,N',N''-tribenzyloxyisocyanuric acid (10) or N,N',N''-tribenzyloxybiuret (11) and 0.05 g palladium on carbon (Pd/C, 10%) in methanol (100 mL) was kept under hydrogen (r. t., normal pressure) for 1-10 hours. Pd/C was filtered off and methanol was evaporated. The obtained products 5, 12, 13, 14, 16 and 15, respectively, were dried over P 2 O 5 in vacuum and were obtained in practically theoretical yields. N-benzyloxyurea (8) , N,N',N''-trihydroxyisocyanuric acid (16) and its triacetyl ester (17) were prepared according to previously published procedures (6, 14, 15) . RESULTS 
1-(N-hydroxycarbamoyl)benzotriazole

AND DISCUSSION
Chemistry
A reported synthesis of 1-(N-benzyloxycarbamoyl)benzotriazole (2) included the reaction of 1-(N-carbamoylchloride)benzotriazole with benzyloxyamine hydrochloride (15) . In our research, 1,1'-carbonylbisbenzotriazole (1) was used in reactions with the corresponding oxyamine hydrochlorides (benzyloxyhydroxylamine hydrochloride, methoxyamine hydrochloride and ethoxyamine hydrochloride) and triethylamine in dioxane suspension. Compound 1 was prepared in a suspension of 1-H-benzotriazole and a solid triphosgene instead of phosgene in toluene (20 % solution), which is less aggressive, more stable and ecologically more friendly. The use of 1 in reactions with methoxy-, ethoxyand benzyloxy-amines afforded 2, 1-(N-metoxycarbamoyl)benzotriazole (3) and 1-(Nethoxycarbamoyl)benzotriazole (4) with yields of 87, 76 and 82 %, respectively (Scheme 1). Among them, only 2 reacted with hydrogen in the presence of palladium/carbon (Pd/C, 10 %), which resulted in 1-(N-hydroxycarbamoyl)benzotriazole (5) in quantitative yield. Uesato et al. (16) reported the use of benzyloxyisocyanate as a useful building block in the synthesis of hydroxyurea derivatives, while Butula and Jadrijevi}-Mladar Taka~ (14) reported that 2, when heated over 100°C liberates benzyloxyisocyanate which is further trimerized to N,N',N''-tribenzyloxy-triazinone (10), and yields a minor product N,N',N''--tribenzyloxybiuret (11) . In this work, we utilized 2 as a donor of benzyloxyisocyanate, which is very useful for the synthesis of hydroxyurea derivatives. Due to its low solubility in water, 2 and products of its reactions can be easily separated from all water soluble substances and reaction products. When heated up to 130°C in reactions with urea or 4-aminobenzoic acid, in the presence of imidazole as a catalyst, it afforded N-benzyloxybiuret (6) and 4-{[(benzyloxy)carbamoyl]amino}benzoic acid (7) with yields of 68 and 81 %, respectively. Under the same experimental conditions, 1 in the reaction with N-benzyloxyurea (8) and N,N'-bisbenzyloxyurea (9) (17) did not yield the expected di-and trisubstitued biurets (18) . Instead, trimerization occurred and only compound 10 was isolated from the reaction mixture.
Compounds 2, 6, 7, 8, 10 and 11 were hydrogenated with hydrogen under atmospheric pressure at room temperature, in the presence of a catalytic amount of palladium on carbon (Pd/C, 10 %) (14) . The corresponding hydroxyl derivatives, i.e., 1-(Nhydroxycarbamoyl)benzotriazole (5) , N-hydroxybiuret (12) (20), 4-{[(hidroxy)carbamoyl]amino}benzoic acid (13) , N-hydroxurea (14) , N,N',N''-trihydroxybiuret (15) (20) and N,N',N''-trihydroxyisocyanuric acid (16) were obtained in quantitative yields. The synthetic routes and structures of isolated compounds are presented in Scheme 1, whereas their physicochemical data are summarized in Tables I and II. The synthesized set of compounds (Table I) represents different derivatives of hydroxyurea, which can be categorized into several subgroups, i.e., benzotriazole N-carbamoyl derivatives (2, 3, 4 and 5), cyclic-(10, 16 and 17) and acyclic hydroxyurea derivatives (7, 8, 9, 13 and 14), and biuret derivatives (6, 11, 12 and 15). IR spectra of benzotriazole N-carbamoyl derivatives 2 to 5 are characterized with C=O stretching vibrations in the range n C=O from 1728 to 1756 cm -1 . These vibrations are shifted towards higher frequency values compared to urea stretching vibrations due to dipole characteristics of carbamoyl moiety. The NH stretching vibrations of 2 to 5 were observed in the range n NH 3248 to 3310 cm -1 , while in the spectrum of 5 the NHOH stretching vibrations were revealed from n 3554 to 2500 cm -1 as strong broadbands.
1 H NMR spectra of 2 to 5 showed chemical shifts for benzotriazole ring protons in the range from d 7.00 to 8.50 ppm with two characteristic signals, one doublet and one triplet, in addition to benzyl protons in the spectrum of 2 and methyl and ethyl protons in the spectra of 3 and 4, respectively. Chemical shifts, d OH and d NH in 5 were observed as two separated signals, at 8.86 and 8.37 ppm. 13 1749 cm -1 ). In addition, in the spectrum of 17 the n C=O of three ester moieties were found as a single stretching vibration at 1829 cm -1 .
Due to high symmetry and equivalence of functional moieties in the molecules of cyclic hydroxyurea derivatives (10, 16 and 17) , the 1 H and 13 C NMR spectra of these compounds are very simple. In 1 H NMR spectra, the following chemical shifts were revealed at d 7.56-7.46 (H ar. ) and 5.13 ppm (benzyl -CH 2 -) in 10, only one signal for proton in OH in 16 at d 11.11 ppm, and only one signal for CH 3 Compared to stretching vibrations of C=O groups immersed in the triazintrione ring system of cyclic urea derivatives, analogous n C=O , in hydroxyurea and its acyclic derivatives (7, 8, 9, 13 and 11) were observed as a very strong and single stretching vibration at lower frequencies, i.e., at n 1658, 1680, 1668, 1686 and 1652 cm -1 , respectively. The 1 H NMR spectra of compounds 7, 8, 9, 11 and 13, showed typical chemical shifts that correspond to protons in aromatic moieties (7, 8, 9 and 13), the carboxylic group (7 and 13), and to NH and OH protons in hydroxyurea moieties in 13 and 14. Chemical shifts of hydroxyurea NH protons were observed in the range 6.24 to 9.86 ppm while chemical shifts of hydroxyl protons (NH-OH) in the spectra of 13 and 14 were found at d 9.20 and 8.66 ppm, respectively. Comparing these chemical shifts with analogous proton chemical shifts in the spectrum of 16, d N-OH in 1 H NMR spectra of 13 and 14 were observed in a higher field. The corresponding chemical shifts, d C=O , of hydroxyurea moieties of these compounds were found at d 156.91 (7), 160.91 (8), 159.39 (9), 167.997 (13) and 162.51 (14) ppm, and lower in the field compared to d C=O of triazintrione moieties in 10, 16 and 17 by more than 10 ppm (d range 13 to 15 ppm) These differences in chemical shifts can be attributed to the strained triazintrione ring with cyclic poly-hydroxyurea moieties.
The basic structure of all synthesized biuret derivatives (6, 11, 12 and 15) is R 1 (NH)CON(R 2 )CON(R 3 ). The IR spectra of these compounds in the part of functional groups are characterized by one strong stretching vibration for both C=O groups in each spectrum of 6 and 11 (n 1682 and 1716 cm -1 , respectively), hydroxyl biuret group is masked by benzyl moiety, while in 12 and 15 the OH group is free, and two very strong vibrations for C=O were observed at n 1716 and 1676 cm -1 in the spectrum of 12, and at 1718 and 1664 cm -1 in the spectrum of 15. Additionally, in the spectra of 12 and 15, in part of OH, NH 2 and NH stretching vibrations, several broadband vibrations were overlapped in the range from 3340 to 3000 cm -1 , while in the spectra of 6 and 11, only two sharp vibrations in each spectrum were observed, i.e., at n 3360 and 3236 cm -1 in 6 and at 3350 and 3288 cm -1 in 11.
The 1 H NMR spectra of biuret derivatives 6 and 11 were represented by NH 2 
Metabolic activity
To date, there is no data on the cytotoxic effects of synthesized compounds 2-17 on human acute monocytic leukemia THP-1 and human acute T cell leukemia Jurkat cell line, so we investigated the effects of compounds in the 0.001, 0.01, 0.1 and 1 mmol L -1 concentrations of the compounds on the metabolic status of the cells using the MTS assay.
The results of this study showed that compounds 6, 8 and 10 were not cytotoxic up to 1 mmol L -1 to either leukemia cell line tested, nor changed the metabolic status of the cells. Only compounds 7, 14 and 15 influenced the metabolic status of the cells at concentrations lower than 1 mmol L -1 in a manner described below: the toxic effect (~50 %) of 0.1 mmol L -1 of the compound 13 was observed only on THP-1 cells, while compound 15 showed a stimulative effect at 0.1 mmol L -1 concentration on both cell lines, and increased metabolic activity of THP-1 cell line by 45 % and Jurkat cell line by 39 % (data not shown). Compound 7 decreased the metabolic activity of Jurkat cells by~34, 31 and 66 % in respect to control cells, when applied at 0.01, 0.1 (data not shown) and 1 mmol L -1 concentrations (Fig. 1b) , respectively. Such effect was not observed on THP-1 cells; just a slight decrease of metabolic activity was detected at 1 mmol L -1 (Fig. 1a) .
Among sixteen investigated compounds, eleven compounds showed a significant effect on the metabolic status of the cells at a concentration of 1 mmol L -1 (Figure 1 ). Ten compounds were toxic either to both or at least to one type of cells, while compound 5 showed a stimulative effect (of~55 % on THP-1 cells and~25 % on the Jurkat cell line). An extensive (more than 70 %) toxic effect on both cell lines was detected at 1 mmol L -1 for compounds 9, 11, 12, 14 and 15. Compound 16 decreased the metabolic activity bỹ 54 % of the Jurkat cell line, while its acetyl derivative, 17, reduced the metabolic activity of THP-1 by 34 % and of Jurkat cell lines by 43 %. Compounds 2, 3 and 4 showed a decrease in metabolic activity only for THP-1 cells, by 43, 35 and 39 %, respectively.
The cytotoxic effect of N-hydroxyurea 14 is well known and is based on its ability to inhibit the M2 subunit of ribonucleotide reductase by quenching the tyrosine radical (21). Gale et al. (22) reported a cytotoxic effect of N-hydroxybiuret, 12. In this study, both compounds, 12 and 14, showed a strong cytotoxic effect on THP-1 and Jurkat cells, while their corresponding benzyloxy derivatives (6 and 8) showed no activity, presumably because of the blocked OH group and consequently inability to quench the tyrosine radical. On the other hand, structurally similar derivatives, N,N'-bisbenzyloxyurea (9) , and N,N',N''-tribenzyloxybiuret (11), were highly toxic, compared to their hydroxy derivatives 6 and 7, which could imply another mode of action for these compounds. N,N',N''-trihydroxybiuret (15) showed a dose-dependent, opposing effect, being cytotoxic at 1 mmol 
Antibacterial activity
The activity of compounds 2-17 was tested on three different E. coli strains at concentrations of 0.001, 0.01, 0.1 and 1 mmol L -1 . Several compounds showed a significant activity (defined as at least 20 % of decrease in bacterial growth) at concentrations of 1 mmol L -1 and the results are shown in Figure 2 . No activity was observed at lower concentrations. The most efficient compounds were 5, 10 and 15. They decreased the bacterial growth of E. coli DH5a from 63 to 96 %, respectively, of E. coli strain DH5a/pUC18-ermC' from 60 to 86 %, and of strain BL21(DE3)/pET25b(+)-sgm from 50 to 93 %, respectively.
Among the investigated compounds, 10, 16 and 17, showed antibacterial activity. They probably have similar mechanisms of action, though yet unknown, since they are structural analogues. The activity of the two structurally different compounds (5 with a benzotriazole ring and 15 as a biuret derivative) could not be assigned to a similar mechanism like in the case of N,N',N''-trihydroxyisocyanuric acid analogues, hence some other modes of action had to be considered. It is interesting, however, that compounds 5, 7 and 15 showed less evident antibacterial activity, either on the strain resistant to macrolide antibiotics or on the sensitive DH5a strain, while 10, 16 and 17 showed stronger antibacterial activity on the strain resistant to aminoglycoside antibiotics. Aminoglycoside resistant strain expressed 16S rRNA methyltransferase Sgm, a member of the Arm family of enzymes that methylate the N 7 position of residue G1405 within the decoding-or A-site in the small ribosomal subunit (23) . This modification prevents 4,6-disubstituted 2-deoxystreptamine aminoglycosides from binding to the A-site, thus rendering them bacteria resistant (12) .
The additional methyl group changes the form and depth of the aminoglycoside binding pocket, but this rearrangement could simultaneously enable binding of different chemical entities with similar properties. Compounds 10, 16 and 17 are all molecules that could mimic parts of aminoglycoside molecule and could still interact with nucleotides in the modified A-site via nitrogen atoms in a manner similar to kanamycin or related 4,6-disubstituted 2-deoxystreptamine antibiotics. This could result in interference with the protein synthesis and in turn affect the bacterial growth. In this respect, 10, 16 and 17 could even be considered as lead molecules for drug development in the treatment of resistant bacteria that carry Arm methyltransferases as aminoglycoside resistance determinants. Compounds 5, 7 and 15, on the other hand, could accommodate better into unmodified A-site, thus having a more prominent effect on any bacterial strain that is either susceptible to antibiotics, or carries any other resistance determinants, except the Arm enzyme.
Manganese-porphyrin test
Dimethylsulfoxide solutions of compounds 5 and 15 showed instability and release of gas bubbles a few hours after solubilization. Due to a high content of nitrogen and oxygen in both compounds and findings of hydroxyurea as a nitric oxide donor, the corresponding compounds were tested for NO formation using the manganese-porphyrin test (5, 13, 24) . Both 5 and 15 gave positive results (Figure 3) , while all the other tested compounds were negative in the manganese-porphyrin test. Effects on the metabolic status of eukaryotic cells (25) and bacteriostatic activity (26) of NO have been demonstrated earlier and these results are in accord with our findings. Mechanisms and kinetics of NO production from 5 and 15 are out of scope of this paper and will be published elsewhere.
CONCLUSIONS
In this paper, the synthesis of new hydroxyurea cyclic and acyclic derivatives [1-(N-metoxycarbamoyl)benzotriazole (3), 1-(N-ethoxycarbamoyl)benzotriazole (4) , N-benzyloxybiuret (6), 4-{[(benzyloxy)carbamoyl]amino}benzoic acid (7), 4-{[(hydroxy)carbamoyl]amino}benzoic acid (13) and N,N',N''-trihydroxybiuret (15) ] and new synthetic routes for these groups of compounds [1,1'-carbonylbisbenzotriazole (1), N-benzyloxycarbamoyl)benzotriazole (2) , N,N'-bisbenzyloxyurea (9) , N-hydroxybiuret (12) and N-hydroxurea (14) ] are disclosed. Metabolic activity test showed the cytotoxic potential of twelve compounds (2-4, 7, 9 and 11-17 ). In addition, 1-(N-hydroxycarbamoyl)benzotriazole (5) stimulated metabolic activity, while compounds 1-(N-hydroxycarbamoyl)benzotriazole (5) and N,N',N''-trihydroxybiuret (15) were identified as potential NO donors. Six compounds showed antibacterial activity (5, 7, 10 and 15-17). Findings described in this work could be used as guidelines for the preparation of new and modification of existing compounds, offering a model for tested biological effects in the drug discovery process.
